Therapy Areas: Devices
Bonesupport submits FDA application for CERAMENT V
1 April 2025 - Swedish orthobiologics company Bonesupport Holding AB (STO:BONEX) said on Tuesday that it has submitted a market authorisation application to the US Food and Drug Administration (FDA) f...
DDL opens new GMP laboratory for drug-device combination product testing
1 April 2025 - DDL, a provider of package, product, and material testing services, announced on Monday the opening of a new Good Manufacturing Practice (GMP) laboratory for drug-device combination pro...
Abbott receives CE Mark for Volt Pulsed Field Ablation System to treat atrial fibrillation
27 March 2025 - Medical devices and health care company Abbott (NYSE:ABT) announced on Thursday that it has received CE Mark approval in Europe for its Volt Pulsed Field Ablation (PFA) System, designe...
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
26 March 2025 - Clinical-stage life science company Vast Therapeutics announced on Tuesday that the US Food and Drug Administration has granted its ALX1 drug candidate 'Qualified Infectious Disea...
Qlife secures UK approval to initiate clinical trial for Egoo Phe System
25 March 2025 - Swedish medical technology company QLife Holding AB (STO:QLIFE) said on Tuesday that it has received approval from UK authorities to begin a clinical trial for the Egoo Phe System, a d...
Dassault Systèmes invests in Click Therapeutics to expand digital therapeutics beyond clinical trials
19 March 2025 - Healthcare company Dassault Systèmes (Euronext Paris: FR0014003TT8) (DSY.PA) announced on Wednesday that it has invested in Click Therapeutics, a provider of prescription digita...